E2814

· Eisai Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for E2814, covering 2025-06-10 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease [Phase 2]